adriana.polo2025-07-02T15:00:56+02:00mAbxience announces European Commission approval of denosumab biosimilarsadriana.polo2025-07-02T15:00:56+02:00July 2, 2025|
Miguel Martínez-Cava2025-07-02T12:29:30+02:00mAbxience and Corapharm Announce Strategic Licensing Agreement for Biosimilar Candidate in Southeast EuropeMiguel Martínez-Cava2025-07-02T12:29:30+02:00June 2, 2025|
Miguel Martínez-Cava2025-07-02T12:28:58+02:00mAbxience and Abiogen Pharma Announce Strategic Licensing Agreement for Biosimilar Candidate in ItalyMiguel Martínez-Cava2025-07-02T12:28:58+02:00May 26, 2025|